Clinical Trial Update: Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the combination of pemetrexed (ALIMTA) and gefitinib (IRESSA) in never-smoker patients with adenocarcinoma-type non-sma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Iressa (gefitinib)

Snippet

Sponsor: Samsung Medical Center | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN